Literature DB >> 1926176

Pathodynamics of intoxication in rats and mice by enterotoxin of Clostridium perfringens type A.

N Sugimoto1, Y M Chen, S Y Lee, M Matsuda, C Y Lee.   

Abstract

The pathodynamics of lethal intoxication in rats and mice by i.v. administration of enterotoxin of Clostridium perfringens type A was studied using whole animals and isolated organs. A lethal i.v. dose (50 micrograms/kg) of enterotoxin killed anesthetized rats and mice within 4-15 min. Rapid changes of ECG pattern suggestive of hyperpotassemia, rapid fall of blood pressure and transient hyperpnea followed by respiratory depression were observed. Analysis of plasma levels of cations revealed hyperpotassemia in both animal species. On the other hand, enterotoxin (up to 100 micrograms) showed little direct cardiotoxicity on the isolated heart. ECG changes produced by i.v. injection of KCl (0.5 ml of 50 mM) mimicked the ECG changes observed in the intoxicated rats injected with a lethal dose of enterotoxin. Perfusion of rat isolated organs showed that potassium concentration in the eluent from the liver (but not lungs or lower extremities) increased markedly within 1-2 min after the administration of enterotoxin. The amount of potassium liberated from a rat liver was about 133 mumoles, which is sufficient to increase the plasma level of potassium to more than 10 mM. In addition to potassium, cytoplasmic enzymes, such as glutamate oxalacetate transaminase, glutamate pyruvate transaminase and lactate dehydrogenase, were also liberated from the intoxicated liver, indicating that potassium was liberated from hepatocytes by the change in membrane permeability produced by enterotoxin. It is concluded that hyperpotassemia elicited by the cytotoxic action of enterotoxin on hepatocytes caused cardiac failure leading to the death of the intoxicated animals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926176     DOI: 10.1016/0041-0101(91)90067-2

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Susan L Robertson; Juliann Saputo; Archana Shrestha; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

Review 2.  Animal models to study the pathogenesis of enterotoxigenic Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane
Journal:  Microbes Infect       Date:  2012-06-17       Impact factor: 2.700

Review 3.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

4.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

5.  Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin.

Authors:  Hidehiko Suzuki; Koji Hosomi; Ayaka Nasu; Masuo Kondoh; Jun Kunisawa
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.